Baidu
map

Am J Physiol Endocrinol Metab:科学家发现“钾”降血压效果神奇

2017-04-07 Heather_z727 natureworldnews

【多吃富含钾的食物可以降低血压】南加州大学凯斯医学院的研究人员发现,饮食中提高钾的摄入量可以有效的降血压。该研究发表在《美国生理内分泌和新陈代谢》杂志中,研究探索了饮食中钠,钾,血压和钠钾比值之间的关系。研究人员表示:“大家都知道,在饮食中,减少钠的摄入量是一个有效的降血压方法。但是此次研究还证明,提高钾的摄入量具有同样的效果。”富含钾的食物,包括香蕉、红薯、鳄梨、菠菜和豆类。在此次研究中,研究人


【多吃富含钾的食物可以降低血压】南加州大学凯斯医学院的研究人员发现,饮食中提高钾的摄入量可以有效的降血压。该研究发表在《美国生理内分泌和新陈代谢》杂志中,研究探索了饮食中钠,钾,血压和钠钾比值之间的关系。

研究人员表示:“大家都知道,在饮食中,减少钠的摄入量是一个有效的降血压方法。但是此次研究还证明,提高钾的摄入量具有同样的效果。”

富含钾的食物,包括香蕉、红薯、鳄梨、菠菜和豆类。

在此次研究中,研究人员研究了不同人口,介入性分子机制,分析了钠,钾和降低血压之间的关系,在分析过程中,研究人员发现,一些饮食中钾元素含量的高的人群,血压较低。除此之外,在介入性分析中他们观察到,通过一些钾的补充产品,也能达到直接的效果。

近期,在啮齿动物中进行的分子机制试验中发现,在钠元素的帮助下,身体有能力控制钾元素的水平,当血液中钾元素含量高的时候,肾脏就会排除多余的盐和水分。他们甚至把钾当做一种天然的利尿剂。

身体控制钾元素的能力对心脏,神经和肌肉功能都是至关重要的。一份典型的西餐是高钠,低钾的,增加了高血压的风险。根据世界卫生组织的预估,世界上高血压人数已经超过了十亿,这也是中风和心脏病死亡的一大原因。因此专家建议我们从日常饮食做起,过健康生活。

原始出处:

McDonough AA, Veiras LC, Guevara CA, et al. Cardiovascular benefits associated with higher dietary K(+) vs. lower dietary Na(+): evidence from population and mechanistic studies. Am J Physiol Endocrinol Metab. 2017 Apr 1.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896018, encodeId=cea7189601878, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Mar 23 20:18:00 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802409, encodeId=75c41802409c9, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Nov 30 04:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788798, encodeId=ab791e88798f5, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Nov 30 15:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887608, encodeId=dfd2188e60879, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Jan 13 20:18:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185930, encodeId=c0e918593030, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74221626377, createdName=tofsw, createdTime=Sat Apr 08 07:57:11 CST 2017, time=2017-04-08, status=1, ipAttribution=)]
    2018-03-23 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1896018, encodeId=cea7189601878, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Mar 23 20:18:00 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802409, encodeId=75c41802409c9, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Nov 30 04:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788798, encodeId=ab791e88798f5, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Nov 30 15:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887608, encodeId=dfd2188e60879, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Jan 13 20:18:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185930, encodeId=c0e918593030, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74221626377, createdName=tofsw, createdTime=Sat Apr 08 07:57:11 CST 2017, time=2017-04-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1896018, encodeId=cea7189601878, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Mar 23 20:18:00 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802409, encodeId=75c41802409c9, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Nov 30 04:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788798, encodeId=ab791e88798f5, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Nov 30 15:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887608, encodeId=dfd2188e60879, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Jan 13 20:18:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185930, encodeId=c0e918593030, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74221626377, createdName=tofsw, createdTime=Sat Apr 08 07:57:11 CST 2017, time=2017-04-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1896018, encodeId=cea7189601878, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Mar 23 20:18:00 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802409, encodeId=75c41802409c9, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Nov 30 04:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788798, encodeId=ab791e88798f5, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Nov 30 15:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887608, encodeId=dfd2188e60879, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Jan 13 20:18:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185930, encodeId=c0e918593030, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74221626377, createdName=tofsw, createdTime=Sat Apr 08 07:57:11 CST 2017, time=2017-04-08, status=1, ipAttribution=)]
    2018-01-13 guojianrong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1896018, encodeId=cea7189601878, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Mar 23 20:18:00 CST 2018, time=2018-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802409, encodeId=75c41802409c9, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Nov 30 04:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788798, encodeId=ab791e88798f5, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Nov 30 15:18:00 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887608, encodeId=dfd2188e60879, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Jan 13 20:18:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185930, encodeId=c0e918593030, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74221626377, createdName=tofsw, createdTime=Sat Apr 08 07:57:11 CST 2017, time=2017-04-08, status=1, ipAttribution=)]
    2017-04-08 tofsw

    学习了谢谢分享

    0

相关资讯

内分泌性高血压的3个罪魁祸首!

内分泌性高血压是高血压的一种,其罪魁祸首有哪些呢?

Int J Med Sci:中国200余万高血压门诊患者合并症分析:华北地区合并高血脂症和冠心病者比例高

近期,一项由中美学者在全国29家医院200多万高血压患者中进行的研究显示,18%合并糖尿病,9.2%合并高脂血症,14.1%合并冠心病。研究显示,与女性高血压患者相比,男性高血压伴糖尿病的风险增加6%,伴血脂异常的风险增加13%,伴冠心病的风险增17%。此外,值得注意的是,45~59岁的中年高血压人群血脂异常患病率明显要高于<44岁和≥60岁者。口袋里的钱,也会影响高血压及其合并症的流行。研究显示

JASN:尿铵可以预测高血压肾病患者的临床结局!

总之,低铵排泄与高血压肾病患者的死亡和肾功能衰竭相关,即使在那些没有酸中毒的患者中。低铵排泄可以识别正常碳酸氢盐水平的CKD患者,这些患者可能会从酸中毒发生前输入碱性药物进行治疗中受益。

Circulation:γδT细胞介导血管紧张素II诱导的高血压和血管损伤

抗原呈递细胞和适应性免疫T细胞已被报道参与高血压的发展。然而,涉及高血压病理生理学的T淋巴细胞亚群仍不清楚。近期加拿大学者发表研究文章于著名血管期刊Circulation,研究一小部分表达γδT细胞受体(TCR)而不是αβTCR的固有T细胞亚群可能在高血压免疫应答中起作用。本研究目的是确定血管紧张素(Ang)II是否引起γδT细胞的动态变化,γδT细胞缺失阻断Ang II诱导的高血压、血管损伤和T

盘点:诸如布洛芬等止痛药或会增加个体患心脏病的风险

诸如布洛芬和阿司匹林等药物都属于非甾体类抗炎药物(NSAIDs),其在药店和超市专柜随处可见,但卫生保健提供者有时候却认为这些药物会给人们带来慢性的健康问题,比如肾脏疾病,高血压或者心力衰竭。NSAIDs还会同其它药物发生非常危险的作用,比如一些多种类型的血压和血液稀释药物(华法林和阿司匹林)。

Circ Res:20-HETE影响血管功能、触发高血压

20-羟基二十碳四烯酸(20-HETE)是细胞色素P450类花生酸之一,是一种有效的血管活性脂质,其血管作用包括促进平滑肌细胞收缩,迁移和增殖,并与内皮细胞功能障碍和炎症相关。实验动物和人体中20-HETE水平升高与高血压,中风,心肌梗死和血管疾病等相关。近来来自纽约医科大学的学者发表研究型文章《20-羟基二十碳四烯酸信号通过G蛋白偶联受体GPR75(Gq)影响血管功能、触发高血压》于著名血管杂志

Baidu
map
Baidu
map
Baidu
map